Advertising
Showing 1 to 15 of 28 entries
DON'T BUY
Small market cap of $15 million. Sales have not been as good as expected. Expected loss of $.04 in earnings in 2007.
medical services
DON'T BUY
Have got approval from FDA. Estimates have gone down the last 90 days because they hired a large sales staff, but sales are not appearing as quickly as hoped. Earnings are expected to get better for Dec/06, but are still negative going from -$0.08 to -$0.05. Looking out to ’07, they are expecting to earn $0.01.
medical services
DON'T BUY
Has interesting technology that uses flourescent lighting to look inside the lungs re: early stage cancer. Ranks 678 out of 700 in the database, the bottom 10%. The market is waiting for sales to appear.
medical services
WAIT
Have the FDA approval. The challenge in the recent quarter is that sales have been almost non-existant. Now ramping up their sales force which will be an increase in expenses. An excellent product, but a "wait and see" stock. Earnings may take a year, if not longer.
medical services
VAGUE
Waiting for the FDA approval and are fairly confidant they are going to get it. Just signed a marketing agreement with Conmed (CNMD-Q) which is an expert on high tech medical equipment. These 2 things should be a great impetus to put this company considerably higher.
medical services
DON'T BUY
Did a financing and have some cash. Earnings estimates are for losses, $0.06 in 2005 and $0.02 in 2006. Estimates have been shaved down by about 10% in the last 90 days. Next earnings are due to be reported in 2 weeks. Great product, but still waiting for approval.
medical services
BUY
Have a product for finding colon/lung cancer. The innovation in terms of product will be adopted by the industry.
medical services
HOLD
Hoping to get the FDA pre-market approval very soon and will be able to offer their flourescent device for early lung cancer detection. Interesting speculation.
medical services
WAIT
Interesting technology. They use white light, which is the conventional lighting, for looking inside the body, but also their proprietory flourescent lighting. The challenge is that the company is expected to burn a bunch of cash. Will wait for the sales to start and earnings start to turn.
medical services
BUY on WEAKNESS
Sold his position for tax loss reasons in December. Would like to get back in at around $0.70/0.75. A terrific company. Likes their technology. If they get FDA approval, he would expect a price of $1.85/2.00 in 12/24 months.
medical services
HOLD
FDA gave a pass to proceed with the testing of Onco-Life, so not sure why the stock has not moved. Still likes.
medical services
VAGUE
It is special and interesting stock.
medical services
DON'T BUY
Has interesting technology. Ranks borderline 25% bottom part of the database. Earnings loss of $.11 improved to a loss of $.07 in 04 and $.02 for 05. Wait for FDA approval.
medical services
WEAK BUY
Intermediate buy signal. Has interesting technologies. Speculative.
medical services
BUY
Expect there will be some news out in the next 3/6 months. Good technology. A viable business.
medical services
Showing 1 to 15 of 28 entries

Xillix Technologies Corp(XLX-T) Rating

Ranking : 1 out of 5

Bullish - Buy Signals / Votes : 0

Neutral - Hold Signals / Votes : 0

Bearish - Sell Signals / Votes : 0

Total Signals / Votes : 0

Stockchase rating for Xillix Technologies Corp is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

Xillix Technologies Corp(XLX-T) Frequently Asked Questions

What is Xillix Technologies Corp stock symbol?

Xillix Technologies Corp is a OTC stock, trading under the symbol XLX-T on the (). It is usually referred to as or XLX-T

Is Xillix Technologies Corp a buy or a sell?

In the last year, there was no coverage of Xillix Technologies Corp published on Stockchase.

Is Xillix Technologies Corp a good investment or a top pick?

Xillix Technologies Corp was never recommended as a Top Pick on Stockchase. Read the latest stock experts ratings for Xillix Technologies Corp.

Why is Xillix Technologies Corp stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is Xillix Technologies Corp worth watching?

In the last year 0 stock analysts on Stockchase covered Xillix Technologies Corp. The stock is worth watching.

What is Xillix Technologies Corp stock price?

On , Xillix Technologies Corp (XLX-T) stock closed at a price of $.